Company Profile
Monte Rosa Therapeutics Stock Price, News & Analysis
- Ticker:
- GLUE
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Monte Rosa Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
20.71 USD (+10.93%)
Close
Last updated: June 23, 2026 at 00:00
1.75B USD
Market cap
Why the stock is moving
GLUE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Monte Rosa Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Monte Rosa Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Monte Rosa Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Monte Rosa Therapeutics (GLUE)?
Monte Rosa Therapeutics (GLUE) most recently closed at 20.71 USD, a +10.93% move versus the previous session.
What is the market cap of Monte Rosa Therapeutics (GLUE)?
Monte Rosa Therapeutics currently has a market capitalization of 1.75B USD on BioPharmSignal.
What does Monte Rosa Therapeutics do?
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is GLUE stock listed?
Monte Rosa Therapeutics (GLUE) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Monte Rosa Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Monte?
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Monte Rosa Therapeutics targeting with Monte?
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Rosa?
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Monte Rosa Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.